UK markets closed

ArriVent BioPharma, Inc. (AVBP)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
18.55+0.20 (+1.09%)
At close: 04:00PM EDT
18.55 0.00 (0.00%)
After hours: 04:04PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
Cash flows from operating activities
Net income
-74,578
-69,333
-36,906
Stock-based compensation
1,354
895
424
Change in working capital
15,635
12,596
-7,149
Accounts payable
1,385
1,379
2,800
Other working capital
-57,589
-55,842
-43,631
Net cash provided by operating activities
-57,589
-55,842
-43,631
Cash flows from investing activities
Purchases of investments
-
-25,000
0
Sales/maturities of investments
-
25,000
0
Net cash used for investing activities
-
0
0
Cash flows from financing activities
Debt repayment
-
-
0
Common stock issued
185,631
0
2
Other financing activities
-
-2,414
-
Net cash used provided by (used for) financing activities
183,522
42,859
169,723
Net change in cash
125,933
-12,983
126,092
Cash at beginning of period
191,460
163,372
37,280
Cash at end of period
317,393
150,389
163,372
Free cash flow
Operating cash flow
-57,589
-55,842
-43,631
Free cash flow
-57,589
-55,842
-43,631